(Q67700885)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1717199%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

FK506 treatment of S-antigen induced uveitis in primates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1717199%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference

1 reference

https://api.crossref.org/works/10.3109/02713689109013859

7 November 2022

author name string

Y. Fujino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717199

7 November 2022

M. Mochizuki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717199

7 November 2022

C. C. Chan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717199

7 November 2022

J. Raber

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717199

7 November 2022

S. Kotake

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717199

7 November 2022

I. Gery

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717199

7 November 2022

R. B. Nussenblatt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717199

7 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1717199

7 November 2022

publication date

1 July 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1717199%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

http://www.tandfonline.com/doi/pdf/10.3109/02713689109013859

1 reference

https://api.crossref.org/works/10.3109/02713689109013859

7 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1717199%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1717199%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1717199%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

679-690

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1717199%20AND%20SRC:MED&resulttype=core&format=json

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

17 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.3109/02713689109013859

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro

7 November 2022

2

1 reference

https://api.crossref.org/works/10.3109/02713689109013859

Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506

7 November 2022

6

1 reference

https://api.crossref.org/works/10.3109/02713689109013859

Studies of the effects of FK506 on renal allografting in the beagle dog.

7 November 2022

7

1 reference

https://api.crossref.org/works/10.3109/02713689109013859

FK 506 for liver, kidney, and pancreas transplantation

7 November 2022

12

1 reference

https://api.crossref.org/works/10.3109/02713689109013859

Immunosuppressive effect of FK506 on collagen-induced arthritis in rats

7 November 2022

15

1 reference

https://api.crossref.org/works/10.3109/02713689109013859

A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase

7 November 2022

17

1 reference

https://api.crossref.org/works/10.3109/02713689109013859

A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

7 November 2022

18

1 reference

https://api.crossref.org/works/10.3109/02713689109013859

Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents

7 November 2022

19

1 reference

https://api.crossref.org/works/10.3109/02713689109013859

Cyclosporine: immunology, pharmacology and therapeutic uses

7 November 2022

21

1 reference

https://api.crossref.org/works/10.3109/02713689109013859

S-antigen uveitis in primates. A new model for human disease

7 November 2022

22

1 reference

https://api.crossref.org/works/10.3109/02713689109013859

A simple and rapid method for isolation of retinal S antigen

7 November 2022

23

1 reference

https://api.crossref.org/works/10.3109/02713689109013859

Effects of a new immunosuppressive agent, FK 506, on the efferent limb of the immune responses

7 November 2022

25

1 reference

https://api.crossref.org/works/10.3109/02713689109013859

Cyclosporine-induced specific unresponsiveness to retinal soluble antigen in experimental autoimmune uveoretinitis

7 November 2022

27

1 reference

https://api.crossref.org/works/10.3109/02713689109013859

7 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1717199%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference